![PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse](https://i1.rgstatic.net/publication/317485129_Negative_anti-neutrophil_cytoplasm_antibody_at_switch_to_maintenance_therapy_is_associated_with_a_reduced_risk_of_relapse/links/595f3bbdaca2728c11478465/largepreview.png)
PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
![ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia](http://media.medmedia.at/mm_media/fdr/2018/03/Bildschirmfoto_2018-11-05_um_16.03.00_opt.jpg)
ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia
![ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia](http://media.medmedia.at/mm_media/fdr/2018/03/Bildschirmfoto_2018-11-05_um_16.02.46_opt.jpg)